Tezepelumab: a Differentiated, First-in-class Investigational Therapy For a Broad Population With Severe Uncontrolled Asthma slide image

Tezepelumab: a Differentiated, First-in-class Investigational Therapy For a Broad Population With Severe Uncontrolled Asthma

View entire presentation